TAC neoadjuvant chemotherapy for locally advanced breast cancer can cause nausea and reduced appetite, affecting nutritional status. This study analyzed 41 patients at Bahteramas Kendari Hospital (2023–2024) by comparing BMI and albumin levels before and after chemotherapy. Results showed a decrease in normal BMI (34.1% to 31.7%) and obesity rates (34.1% to 19.5%). Albumin levels also dropped, with normal levels decreasing from 92.7% to 58.5%. TAC chemotherapy significantly impacts nutritional status, emphasizing the need for proper monitoring and management.

Afirah Khairunnisa S. Limba has completed her Bachelor's degree in Medicine at the Faculty of Medicine, Universitas Muslim Indonesia, Makassar, and is currently pursuing her medical professional program. She has a strong interest in oncology research and is dedicated to expanding her knowledge and clinical skills in this field. She actively engages in medical training and research, aiming to contribute to advancements in cancer treatment and patient care.